Sex differences in adverse drug reaction and liver disease

Submitted: 7 June 2017
Accepted: 8 January 2018
Published: 20 March 2018
Abstract Views: 1872
PDF: 766
HTML: 425
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Adverse drug reactions represent a significant public health problem. A share of no small adverse reaction is particularly serious and can even lead to patient's death. Furthermore, hepatitis induced by serious drug reactions is a rare event but potentially fatal. Finally, we know that epidemiological studies have highlighted male gender as an independent predictor of fibrosis progression towards cirrhosis in hepatitis B and C-virus, as well as non-alcoholic steatohepatitis. The importance of considering the differences between the male and female sex in clinical decision-making is crucial. The physiopathology of liver disease is different in the two genres, but these differences are not yet fully known and several potential mechanisms have been identified.



PlumX Metrics


Download data is not yet available.


How to Cite

Para, O., Crispino, P., Barone, N., Macis, S., Airasca, L., Gnerre, P., & Politi, C. (2018). Sex differences in adverse drug reaction and liver disease. Italian Journal of Medicine, 12(1), 15–22.

List of Cited By :

Crossref logo